BioAlliance Pharma appoints Judith Greciet Deputy Chief Operating Officer
BioAlliance Pharma SA announced that it has strengthened its management team with the appointment of Judith Greciet as Deputy Chief Operating Officer, in charge of Operations and R&D.
Judith Greciet joins from Eisai France, a company she managed as President for 3 years. Aged 41, she holds a doctorate of pharmacy in addition to being a graduate of 3rd cycle management and pharmaceutical marketing. Judith Greciet joined Eisai France in June 2007 after successful achievements at Wyeth Pharmaceuticals France (today Pfizer), LFB Group (“Laboratoire Français du fractionnement et des Biotechnologies”, a French bio-pharmaceutical company), Zeneca and Pharmacia, where she hold increasing operational and strategic positions involving a managerial scope.
She particularly focused on optimizing links with all health actors (researchers, academic practitioners, medical doctors, patient associations, health authorities…). She exercised her talents in the oncology and immunology areas with innovative products such as Enbrel (in rheumatology). She has served successively as Head of the Oncology Department and of the Hospital Department where she was notably in charge of hospital antibiotherapy projects.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
